K. Hauser

发表

Studies on the active conformation of NK1 antagonist CGP 49823. Part 1. Synthesis of conformationally restricted analogs.

C. Betschart, S. Veenstra, K. Hauser, 1997 .

Effect of Valproate on In Vivo GABA-Turnover

M. Schmutz, R. Bernasconi, Pierre Martin, 1985 .

NKP608: a selective NK-1 receptor antagonist with anxiolytic-like effects in the social interaction and social exploration test in rats

S. Ofner, W. Schilling, A. Vassout, 2000, Regulatory Peptides.

Alteration of central alpha2- and beta-adrenergic receptors in the rat after DSP-4, a selective noradrenergic neurotoxin

P. Waldmeier, H. Bittiger, S. Bischoff, 1983, Neuroscience.

Differential decrease of the central beta-adrenergic receptor in the rat after subchronic infusion of desipramine and clenbuterol

H. Bittiger, D. Dooley, K. Hauser, 1983, Neurochemistry International.

Topography of substantia nigra innervation by D1 receptor-containing striatal neurons

C. Altar, K. Hauser, C. Anthony Altar, 1987, Brain Research.

SAR of 2-benzyl-4-aminopiperidines: CGP 49823, an orally and centrally active non-peptide NK1 antagonist

S. Ofner, A. Vassout, S. Veenstra, 1996 .

N-[(R,R)-(E)-1-(4-chloro-benzyl)-3-(2-oxo-azepan-3-ylcarbamoyl)-allyl]-N-methyl-3,5-bis-trifluoromethyl-benzamide: an orally active neurokinin NK1/NK2 antagonist.

G. Anderson, N. Subramanian, R. Mah, 2000, Bioorganic & medicinal chemistry letters.

Studies on the active conformation of the NK1 antagonist CGP 49823. Part 21. Fluoro-olefin analogs of tertiary amide rotamers.

S. Veenstra, K. Hauser, P. Felber, 1997 .

SAR of 2-benzyl-4-aminopiperidines NK1 antagonists. Part 21. synthesis of CGP 49823

S. Ofner, C. Betschart, W. Schilling, 1996 .

125I-iodohistidyl-NK-A binding in bovine urinary bladder

J. Heid, H. Bittiger, K. Hauser, 1988, Regulatory Peptides.

Trimipramine, a tricyclic antidepressant exerting atypical actions on the central noradrenergic system.

R. S. Jones, Roland S. G. Jones, H. Olpe, 1985, European journal of pharmacology.

Subchronic infusion of clenbuterol, a beta-adrenergic agonist, decreases the cerebellar beta receptor

D. Dooley, K. Hauser, 1983, Neuroscience Letters.

Ifoxetine, a compound with atypical effects on serotonin uptake.

P. Waldmeier, H. Bittiger, S. Bischoff, 1986, European journal of pharmacology.

Oxaprotiline, a noradrenaline uptake inhibitor with an active and an inactive enantiomer.

P. Waldmeier, P. Baumann, A. Storni, 1982, Biochemical pharmacology.

Effects of subchronic administration of psychoactive substances on the circadian rhythm of urinary corticosterone excretion in rats

A. Häusler, J. Meeker, K. Hauser, 1985, Psychoneuroendocrinology.

Oxaprotiline and its enantiomers: do they open new avenues in the research on the mode of action of antidepressants?

A. Delini-Stula, H. Bittiger, H. Olpe, 1983 .

Phosphinic Acid Analogues of GABA. Part 2. Selective, Orally Active GABAB Antagonists.

W. Froestl, H. Riezen, M. Pozza, 1995 .

CGP57698: a structurally simple, highly potent peptido-leukotriene (pLT) antagonist of the quinoline type.

M. A. Bray, Ariel Felner, K. Giese, 1997, Advances in experimental medicine and biology.

Stereospecificity of behavioural and biochemical responses to oxaprotiline--a new antidepressant.

A. Delini-Stula, P. Waldmeier, H. Olpe, 1982, Advances in biochemical psychopharmacology.

Developmental changes in high-affinity uptake of GABA by cultured neurons

V. Balcar, H. Demieville, K. Hauser, 1989, Neurochemical Research.

CGP 49823, a novel, non-peptidic NK-1 receptor antagonist: in vitro pharmacology

J. Heid, S. Ofner, L. Criscione, 1994, Neuropeptides.

CGP 28014, a new inhibitor of cerebral catechol-O-methylation with a non-catechol structure

P. Waldmeier, H. Bittiger, S. Bischoff, 1990, Naunyn-Schmiedeberg's Archives of Pharmacology.

Pharmacological Profiles of Four New Tetracyclic Dopamine Antagonists, Maroxepine, Citatepine, Eresepine, and Cipazoxapine

A. Delini-Stula, P. Waldmeier, H. Bittiger, 1986 .